Search ⌘K
Tipsheet
An editorial reading of India’s listed companies.
Brief /Earnings / Specialty Chemicals

Veedol accelerates MD exit, names Ghosal as successor

Modest annual results overshadowed by management shuffle: MD Basu exits May 2026, former MD Ghosal returns. Board also recommends 1100% dividend.

2 earlier stories on Veedol Corporation Ltd.
₹22 per share Final dividend recommended for FY27

What's new

  • MD Arijit Basu's resignation accelerated to May 31, 2026 from Nov 3.
  • Rajendra Nath Ghosal appointed MD from June 1, 2026 to March 2027.
  • Standalone revenue up 1.3% to ₹1,546.96 cr; PAT up 8.2% to ₹135.16 cr.

Why it matters

The leadership transition is unusually structured—exiting MD's departure brought forward and a former MD returning. Combined with a massive 1100% dividend, it signals confidence in cash flows but raises questions about management stability.

What we're watching

  • Execution under Ghosal after a long gap.
  • Any further senior departures.
  • Sustainability of dividend payout ratio.

The full read

Veedol Corporation's annual results for FY27 were modest—revenue grew just 1.3% to ₹1,546.96 crore and PAT 8.2% to ₹135.16 crore. But the board meeting was far more notable for what it did to management. Managing director Arijit Basu's resignation, originally taking effect in November 2026, was accelerated to May 31, 2026. Replacing him from June 1 is Rajendra Nath Ghosal, a former MD who will serve until March 2027. The board also recommended a final dividend of 1100% (₹22 per share), absorbing ₹38.33 crore. Separately, the notes confirm a ₹6.56 crore fire loss insurance claim was repudiated, though this was previously disclosed. The leadership shuffle and high payout make this an above-routine results filing.

Mentioned: Arijit Basu · Rajendra Nath Ghosal · ₹22 per share dividend
Primary source BSE filings for VEEDOL NSE filings for VEEDOL Research VEEDOL on Tijori Finance Our reading is derived from the exchange filing. Verify on the exchange before acting.